A FIRST-EVER VIRTUAL SOHN EVENT
Wednesday, September 23, 2020
12PM – 1:30PM EST
All proceeds of the September 23rd gathering will support Rockefeller University’s Dr. Michel Nussenzweig, who is developing a novel therapy for COVID-19.
Dr. Nussenzweig’s potent monoclonal antibodies against SARS-CoV-2 will enter clinical trials this fall. He is using an approach he pioneered several years ago discovering and harnessing neutralizing antibodies against HIV. Gilead Sciences recently acquired the license to develop this new HIV antibody therapy. The Nussenzweig lab continues to spearhead the design of effective therapies against other known and emerging global infectious diseases.
Flatiron Health & Invite Media
Leading investors and scientists deliver cutting-edge healthcare investment insights in support of fighting COVID-19.
Experts at the forefront of their field engage in conversation concerning the current state of healthcare investing.
Will & Kacie Snellings
Josh Wolfe & Lauren Taylor Wolfe
Crescent Rock Capital Management, LP
Crestone Capital, LLC
The Sohn Conference Foundation is dedicated to the treatment and cure of pediatric cancer and supports cutting-edge medical research, state-of-the-art research equipment, and innovative programs. The Foundation raises its funds through the renowned Sohn Investment Conference in New York City and a number of premier investment conferences around the world.
The Sohn Conference Foundation honors the memory of Ira Sohn, a talented Wall Street professional whose life was cut short when he passed away from cancer at the age of 29. Ira’s friends and family founded The Sohn Conference Foundation in New York City in 1995. Since then, investment leaders from across the globe have been inspired to launch partner Sohn Conferences and unite the financial community to support a number of charitable causes. To date, The Sohn Conference Foundation has raised more than $90 million.